Zuckerman Michael MD - Hempstead, New York 11550

Zuckerman Michael MD is categorized under Doctors in Hempstead, NY .

Business Name: Zuckerman Michael MD
Contact Person: Michael Zuckerman
Address: 540 Fulton Avenue, Hempstead, New York 11550
Phone Number: (516) 750-2500
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Lopez Robert MD - Hempstead, NY 11550
Spera Anthony MD - Hempstead, NY 11550
Abouel-Ela Sally H MD - Hempstead, NY 11550
Altman Roman MD - Hempstead, NY 11550
Sethi Nisha K MD - Hempstead, NY 11550
Nathanson Mark MD - Hempstead, NY 11550
Swartz Louis MD - Hempstead, NY 11550
Caselnova Ralph MD - Hempstead, NY 11550
Del Priore Emilio MD - Hempstead, NY 11550
Patel Prakash B MD - Hempstead, NY 11550
Lee Robert C DO - Hempstead, NY 11550
Tio Ruy C MD - Hempstead, NY 11550
Rodnguez Carmen J MD - Hempstead, NY 11550
Mauss I H MD - Hempstead, NY 11550
NU Image Medical Assoc Llp - Hempstead, NY 11550
Lowe Kevin MD - Hempstead, NY 11550
Patel Mahendra MD - Hempstead, NY 11550
Agrawal Arun K MD - Hempstead, NY 11550
Ukpabi Okoro C MD - Hempstead, NY 11550
Sharma Manjoo MD - Hempstead, NY 11550

The company Zuckerman Michael MD provides B2C services in the form of Doctors from its single location in New York. 1 to 4 employees work for Zuckerman Michael MD, and the business now earns $500.000 to $999.999 per annum.

Zuckerman Michael MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Zuckerman Michael MD, please call Michael Zuckerman with the phone number (516) 750-2500 or visit its single location at 540 Fulton Avenue in Hempstead, New York 11550.

The location of the single location can also be found using the coordinates 40.710518,-73.613176. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.